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Abstract
A number of nuclear events occur during apoptosis, including DNA laddering, nuclear lamina breakdown, phosphorylation
of histones H2B and histone H2AX, and the tight binding to chromatin of HMGB1 and CAD, the nuclease responsible for
DNA laddering. We have performed an epistasis analysis to investigate whether these events cluster together in pathways.
We find that all depend directly or indirectly on caspase-3 activation. CAD activation, H2AX phosphorylation and DNA
laddering cluster together into a pathway, but all other events appear to be independent of each other downstream of
caspase-3, and likely evolved subject to different functional pressures.
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Introduction
Apoptosis entails a complex set of events, which must have
evolved to provide a specific advantage to the individual.
However, while the ultimate advantage of cell apoptosis (favouring
in some way the other cells of the organism of the population) is
clear, less clear is the advantage provided by each of the events
occurring during apoptosis, including chromatin condensation,
DNA laddering and nuclear fragmentation.
Fragmentation of DNA to nucleosome-sized fragments, or DNA
laddering, is executed by activated DNA nuclease (CAD) after
caspase-dependent cleavage of the CAD inhibitor, ICAD [1].
Cad2/2 mice have reduced DNA fragmentation during cells
apoptosis, but show no gross developmental abnormality and are
normally fertile [2]. Besides CAD, Endonuclease G released from
the mitochondria and more than 20 other enzymatic activities
have been implicated in apoptotic DNA cleavage [3].
Chromatin condensation, or pyknosis, is morphologically
evident, but does not cause the ‘‘collapse’’ of chromatin.
Condensation by itself does not impair protein mobility: GFP and
most nuclear proteins, including HMGN1, HMGN2, NF1, and
histone H1 retain their mobility in condensed chromatin [4].
Interestingly, only two proteins appear to be immobilized in
condensed apoptotic nuclei: CAD [5] and High Mobility Group
Box 1 (HMGB1) [4]. HMGB1 is an abundant protein with several
roles in transcription, recombination and chromatin organization
[6]. Cells dying in a traumatic way release HMGB1 in the
extracellular space, where it signals tissue damage, trigger
inflammation, activate innate and adaptive immunity responses,
and promote tissue repair (reviewed in [7]). We have thus proposed
that apoptotic cells actively modify their chromatin to retain
HMGB1 and avoid issuing an inflammatory signal [8].
Nuclear fragmentation, or karyorrhexis, occurs because of
lamin A cleavage by caspase-6 [9]. Mice lacking lamin A/C
develop to term with no overt abnormalities, although their
postnatal growth is severely retarded and is characterized by the
appearance of muscular dystrophy [10].
Several post-translational modifications of histones also occur
during apoptosis. Phosphorylation of histone H2B appears to be
linked to nuclear condensation, both in yeast and mammalian cells
[11,12]. Phosphorylation of histone H2AX at Tyr142 and Ser139
was recently shown to be essential to decide whether to repair a DNA
damage or to promote apoptosis [13]. Histones H3 and H4 are
deacetylated during apoptosis, and inhibition of histone deacetylases
with trichostatin A interferes with HMGB1 immobilization [4].
Given the variety of nuclear events occurring in apoptosis, we
have used a typical epistasis analysis, investigating whether
blocking any of the events affects any of the others. In particular,
we were interested to determine possible interconnections between
histone modifications and morphological changes. In the most
extreme outcome, all events might belong to a single cellular
pathway, and then would have evolved together to provide a single
advantage. We find the opposite: most events occur independently
of each other, and thus are separate endpoints, direct or indirect,
that follow the activation executioner caspases.
Results
HMGB1 immobilization in apoptotic nuclei
The immobilization of HMGB1 and CAD during apoptosis has
been demonstrated using GFP fusion proteins and laser photo-
bleaching [4,5]. FRAP (fluorescence recovery after photobleach-
ing) entails photobleaching of a small spot in the nucleus, followed
by repeated imaging of the photobleached spot to measure the
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6234recovery of fluorescence within it (and thus the mixing of non-
photobleached and photobleached but fully functional molecules
from adjacent areas in the nucleus). FRAP is a time-lapse
experiment: the fluorescence in the bleach region is monitored
during a pre-bleach period to determine the initial fluorescence
intensity F(initial), immediately after the bleaching F(bleached) and
until it reaches a final value F(final), when no further increase can
be detected (Figure 1B).
We confirmed, usingFRAP,that inlivingHeLacellsthe recovery
of HMGB1-GFP fluorescence is complete and fast; 80% recovery is
obtained in about 1.5 seconds (Figure 1C). In cells treated with
TNF-a and cycloheximide (CHX) in order to induce apoptosis, the
recovery of fluorescence of HMGB1-GFP is only partial and always
reaches a plateau (Figure 1D). The amount of immobilized
HMGB1-GFP is indicated by the difference between the plateau
level and the 100% recovery limit, and varies among different
apoptotic cells, possibly depending on the heterogeneity in the
progression of the apoptotic process in the cells being imaged.
We then evaluated the mobility of progressive COOH-terminal
truncations of HMGB1, fused in frame to EGFP (Figure 1A).
Western blot analysis verified the expected molecular mass of the
truncated HMGB1-GFP fusion proteins (data not shown). In living
cells, BoxA+B-GFP recovers 80% of initial fluorescence after
about 2.5 seconds, while BoxA, BoxB and BoxB+C-term truncat-
ed proteins were slightly faster than the full-length protein, in
agreement with the notion that the two HMG boxes cooperate in
binding to chromatin, and that the acidic tail reduces the DNA
binding activity of the HMG boxes.
The mobility of the various deletion mutants was reduced in
apoptotic cells as compared to living cells (Figure 1C), as expected.
However, their immobilization in apoptotic cells was not
complete: fluorescence recovery did not reach a plateau, at least
within 12 seconds (Figure 1D). Thus, all fragments bind rather
tightly to apoptotic chromatin, but not as tightly as full-length
HMGB1.
The two HMG boxes have hydrophobic residues in conserved
positions (F37, F102, I121) that anchor them to the minor groove
of DNA [14], and three cysteine residues, of which two (Cys22 and
Cys44) can form a disulfide bond, while the third (Cys105) is free
(Figure 2) [15]. Triple-mutated HMGB1-GFP (mutHMGB1-
Figure 1. The entire HMGB1 protein is required for its immobilization onto apoptotic chromatin. (A) Schematic representation of the
GFP fusion proteins. (B) A typical FRAP from one cell. Fluorescence intensity in the bleached spot is plotted as a function of time. The typical
parameters of a FRAP experiment are shown. (C) FRAP experiments performed in proliferating HeLa cells transiently expressing the various GFP fusion
proteins. Each line corresponds to the average of fluorescence recovery in at least 20 cells. The standard deviation is about 5% over most data points,
and is not shown to avoid clutter. (D) FRAP experiments performed in apoptotic HeLa cells transiently expressing the various GFP fusion proteins.
Each line corresponds to the fluorescence recovery measured in a different cell. Individual cell traces are shown, rather than their average, becauseo f
the high variation among apoptotic cells.
doi:10.1371/journal.pone.0006234.g001
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replaced by alanine, was already shown to have reduced binding
to chromatin [16,17]. We also constructed cysteine-to-serine single
and triple mutants. We tested each mutant by FRAP in
proliferating HeLa cells and in cells forced to undergo apoptosis.
For all HMGB1 mutants the mobile fraction in apoptotic cells
corresponds roughly to 25% of the total pool of fluorescent
protein, not unlike the wt (Figure 2). Therefore, the severe
reduction of either the ability to bind DNA or to form disulfide
bonds does not impair HMGB1 immobilization in the nucleus of
apoptotic cells. These data also imply that oxidation of HMGB1,
that occurs on C105 [18], does not modify HMGB1 binding to
chromatin.
Caspase-3 activation determines HMGB1 immobilization
and histone H2B phosphorylation
Activation of the executioner caspase-3 is a key event in
apoptosis. Activated caspase-3 cleaves ICAD and releases active
CAD, which cleaves the DNA to nucleosome-sized fragments [1].
CAD is then immobilized in apoptotic nuclei [5]. Moreover,
activated caspase-3 cleaves inactive Mst1 and converts it to an
enzymatically active form that is transported to the nucleus and
phosphorylates histone H2B on serine 14 [12]. We then
investigated whether caspase-3 activation also controls HMGB1
immobilization and H2AX phosphoryation.
In 3T3 fibroblasts, the caspase inhibitor z-DEVD-fmk abrogat-
ed HMGB1 immobilization in dying cells (data not shown). We
then used MCF-7 cells, which lack functional caspase-3 [19],
reconstituted with a plasmid expressing caspase-3 (MCF-7/c3) or
with the pBabe/puro empty vector (MCF-7/pv) as a control [20].
We first showed that Mst1 cleavage and H2B S14 phosphorylation
occurred only in MCF-7/c3 cells and not in MCF-7/pv cells
(Figure 3A). However, both MCF-7/c3 and MCF-7/pv cells died
after stimulation with TNF-a and CHX, either by apoptosis
(MCF-7/c3 cells) or a different caspase-3–independent mode of
death that produces extensive morphological changes including
swelling and detachment from the solid support (MCF-7/pv cells)
(data not shown). We then investigated the mobility of HMGB1 in
dying cells treated with TNF-a and CHX: only 20% of HMGB1-
GFP remains mobile in MCF-7/c3 cells, while essentially all
HMGB1 remains mobile in MCF-7/pv cells (Figure 3B).
Taken together, these results indicate that in MCF-7 cells both
H2B S14 phosphorylation and HMGB1 immobilization to
apoptotic chromatin are caspase-3–dependent events.
H2AX S139 phosphorylation is a caspase-3 dependent
event in TNF-a induced apoptosis, but does not mediate
HMGB1 immobilization
Recently Lu et al. [21] demonstrated that during UVA-induced
apoptosis H2AX is phosphorylated by JNK1, and that this post-
translational modification is responsible for the induction of
apoptosis and for CAD-mediated DNA fragmentation. In contrast
to previous results [22], they also demonstrated that UVA-induced
H2AX S139 phosphorylation by JNK1 is completely independent
from caspase-3 activation.
Given these contrasting data, we investigated whether in TNF-a
induced apoptosis H2AX phosphorylation is dependent on
caspase-3 activation. We used proliferating and apoptotic MCF-
7/pv and MCF-7/c3 cells, pre-treated or not with the caspase-3
inhibitor z-DEVD-fmk. In apoptotic MCF-7/pv cells there is no
detectable level of H2AX S139 phosphorylation, while in
apoptotic MCF-7 cells reconstituted with caspase-3 (MCF-7/c3)
there is a strong induction of this histone modification. Moreover,
H2AX S139 phosphorylation is completely abolished by the
treatment with z-DEVD-fmk prior to apoptosis induction
(Figure 4A). Thus, in TNF-a induced apoptosis H2AX S139
phosphorylation is a caspase-3 dependent event.
Our lab has demonstrated that the treatment of apoptotic cells
with the HDAC inhibitor Trichostatin A (TSA) strongly inhibits
HMGB1 immobilization to apoptotic chromatin [4]. Thus, we
tested the concordance of H2AX S139 phosphorylation and
HMGB1 immobilization in TSA-treated apoptotic cells. We found
that the treatment of apoptotic cells with TSA induces histone
hyperacetylation, but does not influence the level of H2AX S139
phosphorylation. HMGB1 mobility is only modestly slowed down,
but not eliminated, in apoptotic cells treated with TSA (Figure 4C).
These results indicate that H2AX S139 phosphorylation alone
is not sufficient to immobilize HMGB1.
Figure 2. HMGB1 immobilization is not mediated by binding to DNA or disulfide bonds. (A) The substitution of F37, F102 and I121
residues with alanines do not impact HMGB1 apoptotic immobilization. FRAP experiments were performed in proliferating and apoptotic HeLa cells
transfected respectively with wt and mutHMGB1. The results are expressed as mean +/2 standard deviation (n=16). (B) The three cysteine residues in
HMGB1 were mutated to serine. FRAP experiments were performed in proliferating and apoptotic HeLa cells transfected respectively with wtHMGB1-
GFP, singly mutated HMGB1 (HMGB1C22S-GFP, HMGB1C44S-GFP and HMGB1C105S-GFP), and triply mutated HMGB1 (HMGB1C22/44/105S-GFP). The
results are expressed as the mean +/2 standard deviation (n=17).
doi:10.1371/journal.pone.0006234.g002
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S14 phosphorylation and does not affect DNA laddering
or HMGB1 and CADimmobilization inapoptotic HeLa cells
To directly test whether H2B S14 phosphorylation could be
involvedinHMGB1and CADimmobilization duringapoptosis,we
abolished by shRNA the expression of the major kinase responsible
for H2B phosphorylation, Mst1 (Figure 5A). H2B phosphorylation
is markedly induced only in control HeLa cells (stably transfected
with empty vector evshRNA) and not in HeLa cells depleted of
Mst1, even if both cell lines equally undergo apoptosis, as
demonstrated by procaspase-3 and 6 cleavage (Figure 5B). Based
on this, we tested the mobility of HMGB1 and CAD in proliferating
and apoptotic HeLa Mst1shRNA and evshRNA stable clones. The
depletionofMst1inHeLacellsundergoingapoptosisdoesnotaffect
DNA laddering, and does not influence the mobility of CAD and
HMGB1, either (Figure S1).
These results indicate that the immobilization of HMGB1 and
CAD is not caused by the phosphorylation of H2B at Ser14;
likewise, phosphorylation of H2B at Ser14 is not required for
DNA laddering.
HMGB1 depletion does not affect DNA laddering, H2AX
and H2B phosphorylation, or CAD immobilization
Both CAD and HMGB1 are immobilized in apoptotic cells, and
might influence each other. To test directly this hypothesis, we
generated HeLa cells stably transfected with a vector encoding
HMGB1 shRNA (HMGB1shRNA), and with the empty vector as
a control (evshRNA). We confirmed by Western Blotting that
HMGB1 expression is abolished in cells stably expressing HMGB1
shRNA (Figure 6A). However, HMGB1 depletion does not impair
the induction of apoptosis, as demonstrated by procaspase-
cleavage and histone post-translational modifications (Figure 6B),
or DNA laddering (Figure S1).
We then analyzed CAD-GFP mobility by FRAP experiments
in control and HMGB1-depleted HeLa cells. Even in the absence
of HMGB1 expression, during apoptosis just a small fraction of
the entire pool of CAD-GFP remains mobile (Figure 6C). Thus,
CAD immobilization does not depend on the presence of
HMGB1.
HMGB1 and CAD immobilization to apoptotic chromatin
do not depend on caspase-6 expression
Besides caspase-3, in mammals there are two other effector
caspases, caspase-6 and 7. Both proteins have some substrates in
common with caspase-3, and both are involved in the regulation
of nuclear changes during apoptosis, including nuclear lamina
breakdown [9,23]. To investigate the role of the different
caspases in the immobilization of HMGB1 and CAD, we first
determined the level of activation of effector caspases in MCF-
7/pv and MCF-7/c3 treated with TNF-a and CHX. Procas-
pase-7 is processed both in apoptotic MCF-7/pv and MCF-7/c3
cells (Figure 7A). Therefore, caspase-7 cannot be responsible for
the immobilization of HMGB1 and CAD in the nucleus of
apoptotic cells. Indeed, procaspase-7 appeared to be processed
to a greater extent in cells expressing caspase-3, suggesting that
its cleavage may in part depend on caspase-3 activation,
probably indirectly.
On the contrary, procaspase-6 is cleaved only in MCF-7/c3
apoptotic cells (Figure 7A). We then tested HMGB1 and CAD
immobilization in HeLa cells depleted of caspase-6 by shRNA
(Figure 7B). FRAP experiments performed in proliferating and
apoptotic HeLa evshRNA and Casp6shRNA cells demonstrate
that caspase-6 depletion does not affect HMGB1 and CAD
mobility, both in proliferating and apoptotic cells (Figure 7C–D).
We conclude that both HMGB1 and CAD immobilization are
specifically dependent on activation of caspase-3, but not of
caspase-6 and 7.
Figure 3. The lack of caspase-3 expression in MCF-7 cells abolishes H2BS14 phosphorylation and preserves HMGB1 mobility in the
nucleus of apoptotic cells. (A) Proliferating (L) and apoptotic (A) MCF-7/pv and MCF-7/c3 cells were probed by Western blotting. MCF-7 cells,
which lack caspase-3, do not cleave Mst1 during apoptosis and do not phosphorylate histone H2B. Mst1 cleavage and H2B phosphorylation are re-
established after caspse 3 re-expression. (B) FRAP experiments were performed in proliferating and apoptotic MCF-7/pv and MCF-7/c3 cells
transiently transfected with HMGB1-GFP. The results are expressed as the mean +/2 standard deviation (n=16). The asterisk indicates that the
difference in the fraction of mobile HMGB1-GFP between apoptotic MCF-7/pv and MCF-7/c3 cells is highly significant (P,0.001, unpaired t-test).
doi:10.1371/journal.pone.0006234.g003
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We have investigated here, using epistasis analysis, five nuclear
events that take place in mammalian cells during apoptosis (DNA
laddering, histone H2B and H2AX phosphorylation, and the
immobilization of CAD and HMGB1 proteins) in order to
delineate whether these events constitute an ordered pathway in
apoptosis, and thus whether any controls any other.
Caspase-3 activation causes DNA laddering (via ICAD
cleavage and CAD activation), the immobilization of CAD,
and histone H2B phosphorylation (via Mst1 kinase activation)
(Figure 8). Lu et al. [21] reported that, upon UV irradiation,
JNK1 phosphorylates H2AX and activates caspase-3; the JNK
inhibitor SP600125 or dominant negative JNK1 not only
suppressed activation of JNK1 but also blocked H2AX
phosphorylation and caspase-3 activation. However, the inhibi-
tion of caspase-3 did not reduce H2AX phosphorylation, leading
to the suggestion that caspase-3 activation is independent from
H2AX phosphorylation. In contrast tothese published results, we
find that in MCF-7 cells undergoing TNF-a induced apoptosis
the phosphorylation of H2AX occurs only when caspase-3 is
expressed and activated (Figures 4A and 8). We cannot exclude,
however, that this difference is due to the specific mode of
apoptosis induction (UV irradiation vs TNF-a plus cyclohexi-
mide) or the particular cell line used.
We find that also HMGB1 immobilization depends on caspase-
3 activation (Figure 8). Our evidence rests on two observations: (1)
the caspase-3 inhibitor z-DEVD-fmk abrogates HMGB1 immo-
bilization in cells treated with TNF-a and CHX (data not shown),
and (2) MCF-7 cells, which do not express caspase-3, do not
immobilize HMGB1 upon apoptosis, unless the expression of
caspase-3 is restored (Figure 3B).
Nuclear lamina breakdown depends on capase 6 activation [9],
which in turns depends on caspase-3 activation (Figure 7). Thus, all
Figure 4. In TNF-a induced apoptosis, H2AX S139 phosphorylation is a caspase-3 dependent event but does not influence HMGB1
immobilization. (A) Western Blot of MCF-7 cells stably transfected with empty vector (MCF-7/pv) MCF-7 cells transfected with caspase-3 (MCF-7/c3).
Cell were either proliferating (L) or apoptotic (A), pretreated with z-DEVD-fmk (A/z-D) or not. The absence of caspase-3 or its inhibition abolish H2AX
phosphorylation. (B) Western Blot of proliferating (L) and apoptotic (A) HeLa cells, treated with 100 ng/ml TSA just prior to apoptosis (A/TSA) or not.
In TSA treated cells H2AX is phosphorylated, but HMGB1 is mobile; thus, the two events do not correlate. (C) FRAP experiments performed in HeLa
cells (living, apoptotic, and apoptotic treated with TSA) transiently expressing HMGB1-GFP. Each line corresponds to the fluorescence recovery
measured in a different cell.
doi:10.1371/journal.pone.0006234.g004
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then examined the downstream cause-effect relationships.
It was previously known that CAD activation causes DNA
laddering, and the absence of H2AX abrogates laddering [21]
(Figure 8). Here we showed that the absence of H2B phosphor-
ylation (via Mst1 knockdown) or the knockdown of Hmgb1 does
not affect laddering. Conversely, laddering does not cause H2B
phosphorylation (which occurs also in Cad2/2 cells, [12], nor
HMGB1 immobilization (HMGB1 is immobilized also in ICAD
overexpressing cells, where no laddering is evident [4].
Elimination of H2B phosphorylation (via knockdown of Mst1) does
not abrogate H2AX phosphorylation, CAD immobilization or
HMGB1 immobilization (Figure 5). H2AX phosphorylation does
not cause HMGB1 immobilization, at least in the presence of TSA
(Figure 4). Knockdown of HMGB1 does not affect H2B phosphor-
ylation, H2AX phosphorylation, or CAD immobilization (Figure 6).
In conclusion, this set of results imply that CAD activation,
DNA laddering, and H2AX phosphorylation and probably CAD
immobilization cluster together in a pathway (grey area in
Figure 8). However, DNA laddering, nuclear lamina breakdown,
H2B phosphorylation, and HMGB1 immobilization are indepen-
dent endpoints. This suggests that these events and the ‘‘DNA
laddering cluster’’ evolved independently, and thus each was
subject to evolutionary pressure in its own right. Thus, the various
endpoints might serve different purposes.
We previously argued that HMGB1 immobilization evolved to
allow differential responses to programmed and accidental cell death
[8]. In fact, apoptotic cells also oxidize HMGB1, via the production
of reactive oxygen species (ROS) by mitochondria where protein p75
has been cleaved by caspase-3, and electron transport has been stalled
[18]. We show here that HMGB1 immobilization does not depend
on its oxidation (Figure 2); thus, even HMGB1 immobilization and
oxidation appear to be separately controlled, albeit both downstream
of caspase-3 activation (Figure 8).
Recently, we have also shown that HMGB1-nucleosome
complexes released from late apoptotic cells are inflammatory and
lead to the production of autoantibodies against histones and DNA,
and thus the pathogenesis of systemic lupus erythematosus (SLE)
[24]. Nucleosomes can only be released from apoptotic cells if the
DNA has been cut; thus, DNA laddering may be responsible for
anti-histone and anti-DNA autoantibody formation in autoimmune
patients. Interestingly, Cad2/2 mice have no overt phenotype;
mice lacking DNAse II, the enzyme that degrades the chromatin of
engulfed cells in macrophages, die because of constitutive
production of interferon b [25], and Dnase22/2 Ifnar12/2 double
mutant mice (that survive excessive interferon b production because
they lack the receptor) develop chronic polyarthritis [26]. Finally,
Cad2/2 Dnase22/2 double mutant mice survive, but have
impaired thymic development [2]. Although these pieces of
information are sparse, the generation of nucleosome-sized
chromatin pieces, and the inability to degrade them further, appear
to cause inflammation and autoimmunity. Against this backdrop,
there must be some countervailing advantage to DNA laddering,
otherwise it would be lost in evolution. The link between HMGB1,
DNA laddering and inflammation/immunity is of theoretical and
practical interest, and deserves further investigation.
Materials and Methods
Cell culture and reagents
HeLa (ATCC), MCF-7/pv and MCF-7/c3 cells (courtesy of
Dr. AD Thor, Department of Pathology, University of Colorado
Health Sciences Center, Denver, CO) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
Figure 5. The knockdown of Mst1 abolishes H2B S14 phosphorylation but does not influence either HMGB1 or CAD immobilization
in apoptotic HeLa cells. (A) HeLa cells were stably transfected with Mst1shRNA (independent clones 1 and 2) or with the empty vector (evshRNA).
Western blotting shows that Mst1 expression is severely reduced in Mst1shRNA HeLa cells. (B) Western blot of living (L) and apoptotic (A) evshRNA
and Mst1shRNA cells (clones 1 and 2). Caspase-3 and caspase-6 are cleaved similarly in both cell lines undergoing apoptosis, while H2BS14
phosphorylation is markedly induced only in evshRNA cells and not in apoptotic HeLa cells depleted of Mst1.
doi:10.1371/journal.pone.0006234.g005
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penicillin and 100 mg/ml streptomycin, in 5% CO2 humidified
atmosphere. Apoptosis was induced by treating the cells with
2 ng/ml human TNF-a (R&D) and 35 mMc y c l o h e x i m i d e
(Sigma). Where indicated, 100 mMz - D E V D - f m k( S i g m a )w a s
a d d e dt oc e l l s1h o u rb e f o r ea p o ptosis induction, or 100 ng/ml
TSA (Sigma) just prior apoptosis induction. Antibodies agaist
H2BS14ph (Upstate) H2B (Upstate), anti-H3ac (Upstate), H3
(Abcam), H2AXS139ph (Upstate), HMGB1 (BD Pharmingen),
Mst1 (Upstate), Caspase-3 (Chemicon), Caspase-6 (Santa Cruz
Biotechnology), Caspase-7 (MBL International Corporation)
were used in Western blotting.
Plasmids
We generated the constructs containing BoxA, BoxB, BoxA+-
BoxB, BoxB+C-term fused in frame to the GFP by cloning into the
XhoI/SacII sites of the vector pEGFP-N1 four different cassettes,
produced by annealing the following pairs of primers using
pEGFP-N1-HMGB1 as template:
–B o x A - G F P : B o x A f o r 5 9-GATCTCGAGATGGGCAAAGGA-
GATCCTAAG-39 and BoxArev 59-GGCCCGCGGCCCTTT-
GGGGGGATGTA-39
– BoxB-GFP: BoxBfor 59-GATCTCGAGATGGACCCCAA-
TGCCCCC-39 and BoxBre: 59-GGCCCGCGGCACCCCCT-
TTTTCGCTGC-39
– BoxA+B-GFP: BoxAfor and BoxBrev
– BoxB+C-term: BoxBfor and CTermrev
59-GGCCCGCGGTTCATCATCATCATCTTCTTCTT-
CACT-39
The annealed PCR products were digested with XhoI/SacII,
purified on a 1.2% agarose gel and cloned into the pGFP-N1
vector. All constructs were checked by double strand sequencing.
A vector for HMGB1 silencing (pHMGB1shRNA) was
generated by cloning annealed oligonucleotides derived from
human HMGB1 cDNA (sense, 59-GGATATTGCTGCA-
TATCGA-39) into pSuperior.puro empty vector (Invitrogen).
We also used the following plasmids:
– pEGFP-N1-HMGB1 [4]
– pEGFP-N1-mutHMGB1 [16]
– pEGFP-N1-CAD (courtesy of Dr. Gergely L. Lucaks) [5]
– pSuperMst1 (courtesy of Dr. Dae-Sik Lim)
– pRS vector (OriGene Technologies Inc., TR20003) and




Transient and stable transfections
For transient trasfections, cells were transfected the day after
seeding using FuGene 6 Trnsfection Reagent (Roche) with a ratio of
3 mlF u G e n et o1mg DNA, following the manufacturer’s instructions.
Figure 6. CAD immobilization during apoptosis is not affected in HMGB1shRNA cells. (A) HeLa cells were stably transfected with
HMGB1shRNA or with the empty vector (evshRNA) as control. Western blotting shows that HMGB1 expression is abolished in HMGB1shRNA cells. (B)
Western blots of living (L) and apoptotic (A) evshRNA and HMGB1shRNA cells show that caspase-3 and caspase-6 are cleaved in both cell lines;
H2BS14 and H2AX phosphorylation are clearly induced in both cell lines. (C) FRAP experiments to measure CAD mobility were performed in living and
apoptotic evshRNA and HMGB1shRNA cells transfected with CAD-GFP. The results are expressed as the mean +/2 standard deviation (n=20).
doi:10.1371/journal.pone.0006234.g006
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dishes and co-transfected using FuGene with 6 mg of the plasmid of
interest and 0.5 mg pEGFP-N1 to check for transfection efficiency.
Fortyeight hours after transfection, 1.5 mg/ml of puromycin
(Clontech) was added to the medium. After ten days of selection,
single resistant clones were picked with sterile tips, amplified and
analysed for protein expression by Western blot.
Fluorescence recovery after photobleaching (FRAP)
To perform FRAP experiments, cells were grown in glass-bottom
petri dishes (LabTek, Nunc), transiently transfected, and induced into
apoptosis when indicated. Photobleaching experiments were per-
formed on a Leica TCS SP2 AOBS confocal microscope equipped
with a 636/1.4 N.A. oil immersion objective at 37uC. To define the
prebleaching plateau, five single-section 12-bit images were acquired
with 66zoom on a small area (47612 mm, pixel size 0.093 mm) to
maximize acquisition speed (107 ms/frame). Bleaching was per-
formed with four 107 ms pulses using the 488 nm and 514 nm lines
of an Ar laser (100 mW nominal output) at 90% power on an area of
1 mm radius. Fluorescence recovery was monitored collecting 100
single-section images at 107 ms intervals with low laser intensity (2%
of the bleach intensity with the single 488 nm laser line, detection
520–650 nm). For quantitative analysis of fluorescencerecovery, data
were doubly normalized as described [28].
The mobile fraction of the protein was calculated by comparing
the fluorescence in the bleached region after full recovery (Ffinal)
with that before bleaching (Finitial) and just after bleaching
(Fbleached) (Figure 1B). In particular, the mobile fraction R is
defined as:
R~ Ffinal {Finitial ðÞ = Finitial{Fbeached ðÞ
Detection of DNA fragmentation
To analyse genomic DNA by gel electrophoresis, ,500,000
proliferating and apoptotic cells were recovered, washed with PBS,
Figure 7. Neither HMGB1 nor CAD immobilization onto apoptotic chromatin depend on caspase-6 expression. (A) Western blot of
living (L) and apoptotic (A) MCF-7/pv and MCF-7/c3 cells. Caspase-7, but not caspase-6, is activated in MCF-7/pv forced to undergo apoptosis using
TNF-a and CHX. Both caspases are activated in apoptotic MCF-7/c3 cells. (B) HeLa cells were stably transfected with Casp6shRNA or with the empty
vector (evshRNA). Western blots show that caspase-6 expression is severely reduced in casp6shRNA HeLa cells. (C) FRAP experiments were performed
in living and apoptotic evshRNA and casp6shRNA HeLa cells transiently transfected with HMGB1-GFP. The results are expressed as the mean +/2
standard deviation (n=20). (D) FRAP experiments were performed in living and apoptotic evshRNA and casp6shRNA HeLa cells transiently
transfected with CAD-GFP. The results are expressed as the mean +/2 standard deviation (n=20).
doi:10.1371/journal.pone.0006234.g007
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EDTA, 0.2% SDS, 200 mM NaCl) containing 500 mg/ml
proteinase K and incubated for 4 hours at 56uC and 0,25 mg/
ml RNase. DNA was precipitated with 2.5 vol of 100% EtOH and
300 mM Na-acetate pH 5.3, washed with 70% EtOH, resus-
pended in 30 ml of water, and analysed by electrophoresis on a
1.5% agarose gel.
Statistical analysis
Pairwise comparisons between continuous data were done using
unpaired two-tailed Student’s t-test.
Supporting Information
Figure S1 The knock-down of Mst1 has no effects on DNA
laddering or HMGB1 and CAD mobility. (A) The knockdown of
Mst1 (lanes 2: Mst1shRNA cells) or HMGB1 (lanes 3:
HMGB1shRNA cells) does not affect nuclear DNA breakdown
during apoptosis. (B) FRAP experiments were performed in living
and apoptotic evshRNA and Mst1shRNA cells transfected with
HMGB1-GFP. The results are expressed as the mean +/2
standard deviation (n=18). (C) FRAP experiments were per-
formed in living and apoptotic evshRNA and Mst1shRNA cells
transfected with CAD-GFP. The results are expressed as the mean
+/2 standard deviation (n=25).
Found at: doi:10.1371/journal.pone.0006234.s001 (1.04 MB TIF)
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